In early 2020, when the COVID-19 pandemic reached New York City, patients began presenting at hospitals within the Mount Sinai Health System with virus-associated anosmia. Although most of these patients regained their sense of smell as they recovered from the virus, approximately one-third continue to experience some degree of anosmia months later. To address this condition, Alfred Marc Carlo Iloreta, MD, Co-Director of Endoscopic Skull Base Surgery and Assistant Professor of Otolaryngology - Head and Neck Surgery and Neurosurgery at the Icahn School of Medicine at Mount Sinai, has launched a therapeutic study to assess the impact of daily omega-3 fatty acid supplementation among patients who have experienced COVID-19-associated anosmia.